Logo image of MAMK

MAXSMAKING INC- CL A (MAMK) Stock Fundamental Analysis

USA - NASDAQ:MAMK - VGG6053R1064 - Common Stock

13 USD
-0.02 (-0.15%)
Last: 11/14/2025, 8:00:00 PM
13 USD
0 (0%)
After Hours: 11/14/2025, 8:00:00 PM
Fundamental Rating

2

MAMK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 48 industry peers in the Textiles, Apparel & Luxury Goods industry. MAMK has an average financial health and profitability rating. MAMK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MAMK was profitable.
MAMK had a negative operating cash flow in the past year.
MAMK Yearly Net Income VS EBIT VS OCF VS FCFMAMK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 0 1M 2M

1.2 Ratios

MAMK has a Return On Assets of 12.41%. This is amongst the best in the industry. MAMK outperforms 93.75% of its industry peers.
MAMK has a better Return On Equity (30.23%) than 83.33% of its industry peers.
The Return On Invested Capital of MAMK (19.45%) is better than 85.42% of its industry peers.
Industry RankSector Rank
ROA 12.41%
ROE 30.23%
ROIC 19.45%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAMK Yearly ROA, ROE, ROICMAMK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 10 20 30

1.3 Margins

MAMK has a Profit Margin of 7.27%. This is amongst the best in the industry. MAMK outperforms 83.33% of its industry peers.
MAMK's Operating Margin of 9.17% is fine compared to the rest of the industry. MAMK outperforms 75.00% of its industry peers.
MAMK's Gross Margin of 16.04% is on the low side compared to the rest of the industry. MAMK is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
OM 9.17%
PM (TTM) 7.27%
GM 16.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MAMK Yearly Profit, Operating, Gross MarginsMAMK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 5 10 15

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MAMK is creating value.
MAMK Yearly Shares OutstandingMAMK Yearly Shares OutstandingYearly Shares Outstanding 2023 5M 10M 15M
MAMK Yearly Total Debt VS Total AssetsMAMK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 17.49 indicates that MAMK is not in any danger for bankruptcy at the moment.
MAMK has a Altman-Z score of 17.49. This is amongst the best in the industry. MAMK outperforms 100.00% of its industry peers.
MAMK has a Debt/Equity ratio of 0.64. This is a neutral value indicating MAMK is somewhat dependend on debt financing.
MAMK's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. MAMK is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z 17.49
ROIC/WACC2.17
WACC8.98%
MAMK Yearly LT Debt VS Equity VS FCFMAMK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 0 1M 2M 3M 4M 5M

2.3 Liquidity

A Current Ratio of 1.71 indicates that MAMK should not have too much problems paying its short term obligations.
MAMK has a Current ratio of 1.71. This is comparable to the rest of the industry: MAMK outperforms 41.67% of its industry peers.
MAMK has a Quick Ratio of 1.43. This is a normal value and indicates that MAMK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.43, MAMK is in the better half of the industry, outperforming 79.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.43
MAMK Yearly Current Assets VS Current LiabilitesMAMK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-36.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MAMK Yearly Revenue VS EstimatesMAMK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 5M 10M 15M 20M 25M

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 118.18, the valuation of MAMK can be described as expensive.
75.00% of the companies in the same industry are cheaper than MAMK, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 25.47, MAMK is valued quite expensively.
Industry RankSector Rank
PE 118.18
Fwd PE N/A
MAMK Price Earnings VS Forward Price EarningsMAMK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAMK is valued more expensive than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 88.71
MAMK Per share dataMAMK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MAMK!.
Industry RankSector Rank
Dividend Yield N/A

MAXSMAKING INC- CL A

NASDAQ:MAMK (11/14/2025, 8:00:00 PM)

After market: 13 0 (0%)

13

-0.02 (-0.15%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap216.06M
Revenue(TTM)26.26M
Net Income(TTM)1.91M
AnalystsN/A
Price TargetN/A
Short Float %7.19%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 118.18
Fwd PE N/A
P/S 8.23
P/FCF N/A
P/OCF N/A
P/B 34.21
P/tB 34.26
EV/EBITDA 88.71
EPS(TTM)0.11
EY0.85%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.58
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.97
Profitability
Industry RankSector Rank
ROA 12.41%
ROE 30.23%
ROCE 34.04%
ROIC 19.45%
ROICexc 19.86%
ROICexgc 19.88%
OM 9.17%
PM (TTM) 7.27%
GM 16.04%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA 1.67
Cap/Depr 56.94%
Cap/Sales 0.06%
Interest Coverage 24.94
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.43
Altman-Z 17.49
F-ScoreN/A
WACC8.98%
ROIC/WACC2.17
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-36.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

MAXSMAKING INC- CL A / MAMK FAQ

Can you provide the ChartMill fundamental rating for MAXSMAKING INC- CL A?

ChartMill assigns a fundamental rating of 2 / 10 to MAMK.


Can you provide the valuation status for MAXSMAKING INC- CL A?

ChartMill assigns a valuation rating of 0 / 10 to MAXSMAKING INC- CL A (MAMK). This can be considered as Overvalued.


What is the profitability of MAMK stock?

MAXSMAKING INC- CL A (MAMK) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for MAMK stock?

The Price/Earnings (PE) ratio for MAXSMAKING INC- CL A (MAMK) is 118.18 and the Price/Book (PB) ratio is 34.21.